Basic science study demonstrating biochemical differences in reactive thiol groups between cardiac and skeletal muscle myosins.
Answers are grounded in this paper and cite their sources.
Distinguishes cardiac from skeletal myosin biochemically; leaves open functional relevance to human cardiac disease or therapy.
Cardiac and skeletal muscle myosins have been treated by N-ethylmaleimide in presence or absence of Mg-ADP. The variations of Ca2+ and K+-ATPase activities and the incorporation of N-[14C]ethylmaleimide into the whole myosin molecule and into its separated subunits (heavy and light chains) have been measured with N-ethylmaleimide treatment for different lengths of time. The results reported here show the following: 1. The Ca2+-ATPase activity of cardiac myosin is activated by N-ethylmaleimide treatment to a lesser extent than that of skeletal myosin. 2. The K+-ATPase activity of both myosins is inhibited in the same quantitative way. 3. The cardiac light chain L1 contains one highly reactive thiol group which is absent from the skeletal light chains. 4. The labelling of three SH-groups localized in the heavy subunits of both myosins induced the same degree of inactivation. 5. The difference observed between the degree of inhibition of the Ca2+-ATPase activity for the two types of myosin with longer treatments appears to be due to differences in the reactivity of the fourth--SH group labelled on the heavy chains.
No takes yet. Share an insight, caveat, or question.
Klotz et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: